Reaching 8.5 million people around the world, it's fair to say last Friday's 2015 World Multiple Sclerosis (MS) Patient Summit was an amazing success story for the heroes who made this conference a reality.
One of the goals of the Affordable Care Act was to make it easier for people to comparison shop for coverage. Prior to the availability of the exchanges created by the law, that was next to impossible for people who didn't have access to employer-sponsored coverage.
The public demurs from facing reality and accepting measures that might fix the problems, based on a misplaced--and manipulated--appreciation of self-reliance and freedom, O'Kane explains and illustrates.
Some critics of high deductible plans have characterized them as "blunt instruments" because they typically are not adjusted to take an individual's or family's income into consideration. Someone making $50,000 a year has to pay the same amount out of his or her own pocket, before insurance kicks in, as someone making $250,000.
One of the most important things is understanding the difference between mental illness and wellness. The more we talk about mental health the way we talk about physical health, the more we can decrease the stigma and shame that often impedes those in our communities from getting the help that they need. Please share your stories, join the discussion and stay tuned!
Given the health care sector's moral mission and massive buying power, how can the sector shift our entire economy toward sustainable, safer products and practices?
The United States spends 50% more on healthcare than any other advanced nation, yet has the worst health outcomes in virtually every category. This means we should be spending less or experiencing improved outcomes. But we see neither. Why?
After ten years of blogging, David is not resting on his laurels. He publishes new posts frequently, has a popular healthcare podcast, and is active on social media.
Today, the Republicans' voted for their 'Work Harder for Less' Budget. It is another shameless attempt to repeal Obamacare, despite all the clear benefits of the health care law.
In the coming weeks, a single drug will revolutionize the U.S. pharmaceutical industry. Zarxio, a drug that reduces infections caused by chemotherapy, is about to become the very first biosimilar drug sold in the United States.
Best practices, conversations and community engagement activities must continue to improve and adjust to the changing dynamics of an increasingly diverse population.
In a perspective piece recently published in Academic Medicine, my coauthors and I argue that our nation's leading AHCs, and the federal programs that support them, must make fundamental changes -- both in how they provide care and how they train the next generation of health care professionals -- to provide the kind of leadership our health care system needs now.
It's been five years since the Patient Protection and Affordable Care Act (PPACA, also called Obamacare) was signed into law. Implementation has occurred in stages over the last few years, but many business owners still have questions about how the law will continue to affect them.
As the Supreme Court prepares to decide the future of the ACA, the conversation has focused on the potential impact of the outcome. Specifically, that striking down federal subsidies for policy holders could create a nation of haves and have nots -- those with coverage and those without.
While we know how much insurers and oil and gas companies dole out to political campaigns and lobbyists, we don't have a clue how much of their cash is used to establish front groups or how much of it winds up in the pockets of either pundits for hire or tax-exempt organizations that do their bidding.
In my junior year at the University of North Carolina at Chapel Hill, a team of four Health Policy and Management classmates and I set out to understa...